BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31876209)

  • 1. BCR-ABL1 positive lymphoblastic lymphoma - should it be treated like a B-lymphoblastic leukemia with
    Takahashi T; Ichikawa S; Ichinohasama R; Harigae H
    Leuk Lymphoma; 2020 May; 61(5):1265-1267. PubMed ID: 31876209
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.
    Oya S; Morishige S; Ozawa H; Sasaki K; Semba Y; Yamasaki Y; Nakamura T; Aoyama K; Seki R; Mouri F; Osaki K; Miyamoto T; Maeda T; Nagafuji K
    Int J Hematol; 2021 Feb; 113(2):285-289. PubMed ID: 32951102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR/ABL1-like acute lymphoblastic leukemia: How to diagnose and treat?
    Chiaretti S; Messina M; Foà R
    Cancer; 2019 Jan; 125(2):194-204. PubMed ID: 30561755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy.
    Płotka A; Lewandowski K
    Acta Haematol; 2022; 145(2):122-131. PubMed ID: 34818644
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Jain S; Abraham A
    Arch Pathol Lab Med; 2020 Feb; 144(2):150-155. PubMed ID: 31644323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia.
    Rizzotto L; Saccenti E; Sofritti O; Daghia G; Volta E; Caprini E; Lupini L; Tammiso E; Bardi A; Lista E; Ciccone M; Russo G; Negrini M; Cuneo A; Rigolin GM
    Leuk Lymphoma; 2013 Sep; 54(9):2065-7. PubMed ID: 23323950
    [No Abstract]   [Full Text] [Related]  

  • 7. Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript.
    Shin SY; Cho JH; Kim HJ; Jang JH; Lee ST; Kim SH
    Ann Lab Med; 2015 Jan; 35(1):159-61. PubMed ID: 25553301
    [No Abstract]   [Full Text] [Related]  

  • 8. The e1a3 BCR-ABL1 fusion transcript in philadelphia chromosome-positive acute lymphoblastic leukemia.
    Langabeer SE
    Ann Lab Med; 2015 Sep; 35(5):540-1. PubMed ID: 26206693
    [No Abstract]   [Full Text] [Related]  

  • 9. BCR-ABL1-like B-lymphoblastic leukemia/lymphoma: Review of the entity and detection methodologies.
    Conant JL; Czuchlewski DR
    Int J Lab Hematol; 2019 May; 41 Suppl 1():126-130. PubMed ID: 31069976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
    De Benedittis C; Papayannidis C; Venturi C; Abbenante MC; Paolini S; Parisi S; Sartor C; Cavo M; Martinelli G; Soverini S
    BMC Cancer; 2017 Aug; 17(1):523. PubMed ID: 28779753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A near-haploid clone harboring a BCR/ABL1 gene fusion in an adult patient with newly diagnosed B-lymphoblastic leukemia.
    Peterson JF; Ketterling RP; Huang L; Finn LE; Shi M; Hoppman NL; Greipp PT; Baughn LB
    Genes Chromosomes Cancer; 2019 Sep; 58(9):665-668. PubMed ID: 30790375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.
    Roberts KG; Pei D; Campana D; Payne-Turner D; Li Y; Cheng C; Sandlund JT; Jeha S; Easton J; Becksfort J; Zhang J; Coustan-Smith E; Raimondi SC; Leung WH; Relling MV; Evans WE; Downing JR; Mullighan CG; Pui CH
    J Clin Oncol; 2014 Sep; 32(27):3012-20. PubMed ID: 25049327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA signature in BCR-ABL1-like and BCR-ABL1-positive childhood acute lymphoblastic leukemia: similarities and dissimilarities.
    Akbari Moqadam F; Lange-Turenhout EA; van der Veer A; Marchante JR; Boer JM; Pieters R; den Boer M
    Leuk Lymphoma; 2014 Aug; 55(8):1942-5. PubMed ID: 24164534
    [No Abstract]   [Full Text] [Related]  

  • 14. MUC4 expression by immunohistochemistry is a specific marker for
    Kaumeyer B; Fidai S; Sukhanova M; Yap KL; Segal J; Raca G; Stock W; McNeer J; Lager AM; Gurbuxani S
    Leuk Lymphoma; 2022 Jun; 63(6):1436-1444. PubMed ID: 35171727
    [No Abstract]   [Full Text] [Related]  

  • 15. The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.
    Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G
    Haematologica; 2010 Oct; 95(10):1683-90. PubMed ID: 20534699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p210 BCR-ABL1 positive pediatric B-lineage acute lymphoblastic leukemia presenting with hypercalcemia.
    Bommannan K; Totadri S; Sachdeva MU; Naseem S; Trehan A; Varma N
    Leuk Lymphoma; 2017 Feb; 58(2):501-502. PubMed ID: 27339816
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of
    Baer C; Meggendorfer M; Haferlach C; Kern W; Haferlach T
    Haematologica; 2022 Feb; 107(2):562-563. PubMed ID: 34758608
    [No Abstract]   [Full Text] [Related]  

  • 18. Mucin 4 protein is expressed in B-acute lymphoblastic leukemia and is restricted to BCR::ABL1-positive and BCR::ABL-like subtypes.
    Gestrich CK; De Lancy SJ; Kresak A; Sinno MG; Yalley A; Pateva I; Meyerson H; Shetty S; Oduro KA
    Hum Pathol; 2023 Jun; 136():75-83. PubMed ID: 37023866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review.
    Kim MJ; Yoon HS; Lim G; Kim SY; Lee HJ; Suh JT; Lee J; Lee WI; Park TS
    Cancer Genet Cytogenet; 2010 Jan; 196(2):184-8. PubMed ID: 20082857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel e8a2 BCR-ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    McCarron SL; Kelly J; Coen N; McCabe S; Fay M; O'Dwyer M; Hayden PJ; Langabeer SE
    Leuk Lymphoma; 2011 May; 52(5):919-21. PubMed ID: 21338279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.